Assessing the Effects of Non-Pharmaceutical Interventions During COVID-19 on Reported Infectious Diseases in Poland: An In-Depth Study from 2014 to 2022 - Takeaways - MDSpire

Assessing the Effects of Non-Pharmaceutical Interventions During COVID-19 on Reported Infectious Diseases in Poland: An In-Depth Study from 2014 to 2022

  • By

  • Abdulla Zahi Hourani

  • Abdelrahman Abdelsalam

  • Arman David Sürmeli

  • February 3, 2026

  • 0 min

Share

  • 1

    The study investigates the impact of non-pharmaceutical interventions (NPIs) on 17 notifiable infectious diseases in Poland from 2014 to 2022.

  • 2

    NPIs implemented during the COVID-19 pandemic likely reduced the transmission of both COVID-19 and other endemic infectious diseases in Poland.

  • 3

    Data for the study was collected biweekly from the National Institute of Public Health, covering various infectious diseases with significant annual incidence.

  • 4

    The analysis categorized diseases into five groups, including respiratory, gastrointestinal, sexually transmitted, vector-borne, and wound-borne diseases.

  • 5

    The study aims to inform future infection control strategies by quantifying the long-term effects of NPIs on infectious disease incidence.

Original Source(s)

Assessing the Effects of Non-Pharmaceutical Interventions During COVID-19 on Reported Infectious Diseases in Poland: An In-Depth Study from 2014 to 2022

  • by Abdulla Zahi Hourani, Abdelrahman Abdelsalam, Arman David Sürmeli

  • February 3, 2026

Related Content

Early-Phase Oral Antiviral Use and Post–COVID-19 Condition in Outpatients

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Clinical characteristics and antibody responses to Omicron variants among pregnant women in China during the December 2022–April 2023 COVID-19 pandemic wave